Assessing Risks: Neurological and Respiratory Impacts of New RSV Treatment

This chapter delves into the neurological and respiratory dangers linked to a novel RSV treatment for infants, spotlighting concerning statistics on convulsions and infections. It scrutinizes the disparity between the manufacturer’s efficacy assertions and the actual outcomes, while also addressing significant gaps in the public's awareness and the monitoring of adverse effects.